Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Bristol-Myers Squibb Co. · PHARMACEUTICAL PREPARATIONS · Now $54.95
+3.9% in 3d after detection
Post-detection moves
1h
—
1d
+1.7%
3d
+3.9%
7d
-0.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS